Skip to content

Research on the Value of Genomics Research Based on Ultrasound Endoscopic Biopsy in the Differential Diagnosis and Prognostic Evaluation of Pancreatic Occupancy

Research on the Value of Genomics Research Based on Ultrasound Endoscopic Biopsy in the Differential Diagnosis and Prognostic Evaluation of Pancreatic Occupancy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04986215
Enrollment
300
Registered
2021-08-02
Start date
2020-10-01
Completion date
2023-09-01
Last updated
2021-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Space Occupying

Brief summary

To clarify the value of genomic testing in the clinical diagnosis or prognosis of pancreatic space occupation, provide a basis for the selection of clinical diagnosis methods for pancreatic space occupation, optimize clinical management strategies, and improve the prognosis of patients.

Interventions

None listed

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-85, no gender limit 2. Imaging examinations suggest that the clear pancreas has clear space-occupying lesions 3. Admitted to our department, ready to undergo endoscopic ultrasound biopsy to confirm the diagnosis

Exclusion criteria

1. There are contraindications for endoscopic ultrasound biopsy 2. Failed to join the group or refused follow-up due to various reasons

Design outcomes

Primary

MeasureTime frameDescription
Differential microRNA detected by sequencingJune 2023The diagnosis of microRNA in pancreatic space occupying
Differential mRNA detected by sequencingJune 2023The diagnosis of mRNA in pancreatic space occupying
Differential lncRNA detected by sequencingJune 2023The diagnosis of lncRNA in pancreatic space occupying

Countries

China

Contacts

Primary ContactXiangyu Kong, associate professor
xiangyukong185@hotmail.com13564644397

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026